Literature DB >> 1329509

Topics in clinical pharmacology: ganciclovir.

S Paul1, S Dummer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329509     DOI: 10.1097/00000441-199210000-00010

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  6 in total

Review 1.  CMV-specific immune reconstitution following allogeneic stem cell transplantation.

Authors:  Emily Blyth; Barbara Withers; Leighton Clancy; David Gottlieb
Journal:  Virulence       Date:  2016-08-09       Impact factor: 5.882

2.  Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group.

Authors:  X J Zhou; W Gruber; G Demmler; R Jacobs; P Reuman; S Adler; M Shelton; R Pass; B Britt; J M Trang; R J Whitley; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene.

Authors:  W R Smythe; H C Hwang; A A Elshami; K M Amin; S L Eck; B L Davidson; J M Wilson; L R Kaiser; S M Albelda
Journal:  Ann Surg       Date:  1995-07       Impact factor: 12.969

4.  Conditional ablation of cerebellar astrocytes in postnatal transgenic mice.

Authors:  C L Delaney; M Brenner; A Messing
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

5.  In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer.

Authors:  M Ohashi; F Kanai; T Tanaka; K H Lan; Y Shiratori; Y Komatsu; T Kawabe; H Yoshida; H Hamada; M Omata
Journal:  Jpn J Cancer Res       Date:  1998-04

6.  The effectiveness and safety of Tanreqing Injection combined with ganciclovir on the treatment of respiratory syncytial virus pneumonia in children: A protocol for systematic review and meta-analysis of randomized controlled trials.

Authors:  Wei-Jun Zhu; Xuan Zhou; Juan Cao; Yu Shi
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.